ThePrintPod: Demand soars for twice-a-year jab to lower bad cholesterol. Here’s how it works

Inclisiran was developed by Novartis & launched in India in January this year under brand name Leqvio. Cardiologist vouch for benefits, say it has been a useful addition to therapies.